FDA Releases Guidance on Biosimilar and Reference Product Promotion and Advertising Earlier this month, the FDA released its guidance on advertising and promotion of biosimilars and reference products, with questions and answers for industry. The guidance provides suggestions (not rules) by the FDA for the characterization of biosimilars and interchangeable products in promotional materials, including … Continue reading Biosimilar Bytes